Medical Device Study Presents Detailed View of Key Budget and Staffing Metrics for Market... ( CHAPEL HILL N.C. Nov. 9 2012 /- Earli...)

Medical Device Study Presents Detailed View of Key Budget and Staffing Metrics for Marketing Groups

Date:11/9/2012

CHAPEL HILL, N.C., Nov. 9, 2012 /PRNewswire/ -- Earlier this year, a Top 5 medical device company reported revenue from emerging markets increased 20 percent in fiscal year 2012 and now represents 11 percent of the company's total revenue. Likewise, a much smaller medical device company reported this year that emerging markets represent 6 percent of the company's total revenue - up from 2 percent just four years ago.

As emerging markets continue to play a growing role in medical device organizations' success, companies need to adjust their marketing groups to ensure their budgets, staffing, and activities are aligned to capitalize on emerging markets. A recent survey involving large medical device companies found, on average, 85 percent of their marketing group FTEs were located in mature markets while 15 percent were located in emerging markets.

"Medical Device Marketing Excellence: Optimizing Group Structure and Operations" is a new report from research and consulting firm Best Practices, LLC that will help medical device marketing executives evaluate their groups to ensure they remain properly staffed and focused to maximize their productivity for the U.S. marketplace as well as the outside-U.S. market.

In addition to presenting medical device marketing benchmarks around budgets and staffing (by geography and company revenue), the study also reviews how marketing functions are organized. It also highlights anticipated trends such as increased or decreased spending and staffing on a range of marketing activities.

The study presents two segments - large companies and emerging companies - to inform marketing leaders from both large and small companies. This report contains more than 400 metrics and is based on research and information provided by 15 medical device leaders from 15 companies.

The 68-page report includes a chapter dedicated to qualitative
'/>"/>

SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London

Post Your Comments:

(Date:5/24/2013)... , May 24, 2013 An international roster of ... May 18, in Santa Monica, Calif. ... lung-sparing therapies for MPM, a rare form of cancer ... the pleura, the lining of the chest. ... Blood Institute, the 3rd Annual International Symposium on Lung-Sparing ...

(Date:5/24/2013)... , May 24, 2013 China Biologic Products, ... leading fully integrated plasma-based biopharmaceutical company in ... recently learned from a public announcement issued by Shanghai ... company listed on Shenzhen Stock Exchange, that on May ... ("Ms. Chan"), one of the shareholders of the ...

(Date:5/24/2013)... -- In accordance with Rule 17.1 and Rule 2.9 of ... States Exchange Act, Echo Pharma Acquisition Limited ("Royalty Pharma") today ... ELN). Background On 2 May 2013, ... the entire of the issued and to be issued share ... On 20 May 2013, Royalty Pharma announced the ...

Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2 International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3 China Biologic Comments on the Proposed Shanghai RAAS Transaction 2 China Biologic Comments on the Proposed Shanghai RAAS Transaction 3 China Biologic Comments on the Proposed Shanghai RAAS Transaction 4 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9

[0] International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma [0] China Biologic Comments on the Proposed Shanghai RAAS Transaction [0] Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements

... YORK, June 15, 2007 /PRNewswire/ -- Telomerase Activation,Sciences, Inc. ... Anti-Aging Trial of TA-65, the first human trial,ever to ... Activator. Statistically significant,results were found in those taking TA-65 ... -- Improvement in immune system function, ...

... Trial Presented at EULAR, BARCELONA, Spain, June ... the European League Against Rheumatism (EULAR),Annual European ... spondylitis (AS) who received REMICADE(R) (infliximab),over two ... addition, REMICADE-treated patients showed sustained,reductions in spinal ...

Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07,Teleconference to Answer Questions About TA-65, Their Telomerase,Activator With Proven Age Management Benefits Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation

(Date:5/25/2013)... 25, 2013 According to a ... Market, 2013–2018", published by MarketsandMarkets is expected to ... of 5.54% which analyzes and studies the major ... Europe, Asia, and Rest of the World. , ... Tables , 87 Figures , ...

(Date:5/25/2013)... According to world-renowned scholars, Queen Cleopatra ... women that ever lived. Cleopatra’s legendary beauty moved nations ... most powerful men in her time. Cleopatra was also ... her skin glowing and fresh, from her legendary milk ... oil and cyprus grass. , Cleopatra was said to ...

(Date:5/25/2013)... May 25, 2013 IBISWorld estimates that revenue ... an average annual rate of 28.7% to $1.0 billion in ... 2013. From 2002 and 2008, no new cell therapy products ... relatively modest growth during that period. In the years since, ... new products. This factor contributed to the industry's fast growth ...

(Date:5/25/2013)... DF (PRWEB) May 25, 2013 Ayurveda ... sanscrit: "knowledge or wisdom of life". While a medical science, ... the transformation of consciousness. Its fundamental philosophy is that disease ... our environment. In order to re-establish optimal health, one must ... adopt a life style which brings us back into perfect ...

(Date:5/25/2013)... 2013 The current residents of Back2Basics - ... the B2B staff all came together Saturday, May 18th to ... of Indian Cuisine, the residents got up to thank Roy ... on their road to recovery, and giving them a second ... center in 2010 after realizing the need for a long-term ...

Breaking Medicine News(10 mins):Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2 Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3 Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3 Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2 Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3 Health News:Fundamentos de Ayurveda in Mexico (Ayurvedic Principles) Offered by Escuela de Ayurveda de California 2 Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2

[0] Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets [0] The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician [0] Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld [0] Fundamentos de Ayurveda in Mexico (Ayurvedic Principles) Offered by Escuela de Ayurveda de California [0] Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary

... Holdings, Inc. (NYSE Alternext US: KUN) ("China Shenghuo" ... previous,announcements, it has filed with the United States ... Report on Form 10-KSB/A for the year,ended December ... 10-Q/A for the,first quarter ended March 31, 2008 ...

... 20 Again next year, the American Pain,Society (APS), ... programs in its acclaimed Clinical Centers of Excellence in ... until Dec. 14,2008. , ... Awards Program,honors forward-thinking teams of healthcare professionals who are ...

... volunteers from State,Farm Bayou Classic(R), organizers from KaBOOM! and residents ... 28 to build a new, safe,playground at the Abramson Science ... is based on drawings provided by,children who attended a Design ... The new playground will provide more than 400 children ...

... Contreras, 61, and Ramon Pichardo, 58, were sentenced today to ... the Medicare program in connection with a $6.8 million HIV ... the Criminal Division and U.S. Attorney R. Alexander Acosta of ... , Judge Federico A. Moreno of ...

... differ by almost $37,000 per patient, study finds , , ... treating colorectal cancer can vary by tens of thousands ... researchers compared the eight most commonly prescribed therapeutic regimens ... ambulatory care centers across the United States. , ...

... in these young adults points to danger, study finds ... the arteries of children of smokers can be detected ... Dutch study finds. , "Smoking in families is harmful ... in many other studies," said research leader Dr. Cuno ...

China Shenghuo Announces Restated Results For Full Year 2007 & First Quarter 2008, Reports Results For Second & Third Quarter 2008 American Pain Society Accepting Applications for Clinical Centers of Excellence in Pain Management Awards State Farm Bayou Classic and KaBOOM! Team Up to Build New Playground in Just One Day Miami Physicians Sentenced to Prison for Their Roles in a $6.8 Million Medicare Fraud Scheme Colorectal Cancer Treatment Costs Vary Widely Parent Smoking During Pregnancy Raises Kids' Heart Risks

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

Medicine Products:

NPM-ALK, t(2;5) Translocation, Quantitative by RT-PCR, Fluid Nortriptyline by HPLC Norwalk Virus Norpace